MCM 2-37 Enzyme Regulation and Clinical Application Flashcards
allosteric enzymes frequently operate at..
control points in metabolic pathways
ex)feedback inhibition
allosteric enzymes do not follow michaelis mentron kinetics (TF)
K0.5?
True
allosteric enzymes show and S-shaped curve rather than rectangular hyperbola
K0.5 = [S] giving half maximal activity
allosteric modulators can affect the
either K.05 or Vmax and be activators or inhibitors
allosteric regulation
substances (allosteric modulators) binding the enzyme somewhere other than the active site and modifying its activity
heterotrophic vs homotrophic effector
heterotrophic effector - when the allosteric modulator is NOT the substrate for the enzyme
homotrophic - when the allosteric modulator IS the substrate for the enzyme
ATCase example
allosteric enzyme example
catalyzes initial step in pyrimidine (CTP) synthesis pathway
CTP is an allosteric inhibitor, working through negative feedback mechanism shifting the enzyme equilibrium towards less active T state. (shift curve to left) by preferentially binding and stabilizing the low-affinity conformation of ATCase (T state)
ATP is an allosteric activator, shifting the enzymes equilibrium towards the more active R state by binding and stabalizing the high affinity conformation of ATCase
reversible covalent modification
example?
mechanism involves substances being covalently bound to the enzyme in a reversible manner (phosphorylation, methylation, ubiquitination) which can cause in the enzyme
conformational change altering catalysis
altering cellular localization of the enzyme
altering interactions with other enzymes
glycogen phosphorylase is an example of this type of enzyme. Phosphorylation activates it, dephosphorylation deactivates it.
irreversible covalent modification
involves substances being permanently covalently bound to the enzyme. enzymes regulated this way are synthesized in inactive form and then irreversibly activated where/when needed.
ex) zymogens
Zymogens
examples?
example of irreversible covalent modification
inactive precursors to proteases that are cleaved and activated by other proteases
- digestive enzymes in stomach/pancreas (pepsin, chymotrypsin)
- clotting cascade enzymes (thrombin)
- caspases (involved in programmed cell death; caspase cascade)
protein-protein interactions
examples?
involves specific proteins interacting with enzymes to alter their activity.
protease inhibitors, for example, interact with proteases and inactivate them. otherwise would be permanently activated.
anti-thrombin III inactivates thrombin and a number of proteases in the clotting cascade and arrests clotting
alpha-1-antitrypsin (AAT) inhibits elastase in the lungs.
signaling cascade enzymes (like PKA and calmodulin) are generally regulated via
protein-protein interactions
digestive enzymes are synthesized as
zymogens (protease precursors) stored in pancreas. response to food availbaility signals, released into duodenum where enteropeptidase cleaves trypsinogen to trypsin which cleaves others (proteolytic cascade)
anticoagulants
mimic vitamin K, are competitive inhibitors to the vitamin-K-dependant enzyme, they mimic vitamin K deficiency. preventing/slowing clotting
What is TPA and when given?
TPA - serine protease that hydrolyzes plasinogen to plasmin which break up fibrin clots. combat one protease cascade with another.
administered therapeutically for heart attack and stroke
anti-thrombin (AT III) deficiency
can cause?
treatment?
autosomal dominant interited genetic disease, patients have one missing or defective copy of gene
excessive clotting (Thrombosis) blood clots form inappropriately (in legs or lungs) after serious injury or oral contraceptive use. can be fatal
treated with long term anti-coagulants